abrdn Australia Equity Fund, Inc is a US-based company operating in industry. The company is headquartered in Philadelphia, Pennsylvania. abrdn Australia Equity Fund, Inc. (Fund) is a non-diversified, closed-end management investment company. The Fund's principal investment objective is long-term capital appreciation through investment primarily in equity securities of Australian companies listed on the Australian Stock Exchange Limited (ASX). Its secondary objective is current income, which is expected to be derived primarily from dividends and interest on Australian corporate and governmental securities. The Fund will invest at least 80% of its net assets, plus the amount of any borrowings for investment purposes, in equity securities, consisting of common stock, preferred stock and convertible stock, of Australian companies. The company invests in various sectors, such as financials, materials, healthcare, utilities, energy, real estate, consumer discretionary, industrials, information technology, and communication services. The Fund’s investment manager is abrdn Asia Limited.
根據最新的財務報表(Form-10K),Medical Care Technologies Inc 的總資產為 $0,淨손실為 $0
IAF 的關鍵財務比率是什麼?
Medical Care Technologies Inc 的流動比率為 0,淨利潤率為 0,每股銷售為 $0。
abrdn Australia Equity Fund, Inc 的收入按細分市場或地理位置如何劃分?
Medical Care Technologies Inc 주요 수익원은 High Value Sport Collectibles이며, 최신 수익 발표에서 수익은 1,071,812입니다. 지역별로는 China이 Medical Care Technologies Inc의 주요 시장이며, 수익은 1,071,812입니다.
abrdn Australia Equity Fund, Inc 是否盈利?
no,根據最新的財務報表,Medical Care Technologies Inc 的淨손실為 $0